Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Converting cancer genes into killer genes.

Da Costa LT, Jen J, He TC, Chan TA, Kinzler KW, Vogelstein B.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4192-6.

2.

P53, cell cycle control and apoptosis: implications for cancer.

Kastan MB, Canman CE, Leonard CJ.

Cancer Metastasis Rev. 1995 Mar;14(1):3-15. Review.

PMID:
7606818
3.
4.

The promise and obstacle of p53 as a cancer therapeutic agent.

Willis AC, Chen X.

Curr Mol Med. 2002 Jun;2(4):329-45. Review.

PMID:
12108946
5.

Induction of genetic instability by gain-of-function p53 cancer mutants.

Xu Y.

Oncogene. 2008 Jun 5;27(25):3501-7. doi: 10.1038/sj.onc.1211023. Epub 2008 Jan 28. Review.

PMID:
18223686
6.

Oncogenes and tumor-suppressor genes.

Lehman TA, Reddel R, Peiifer AM, Spillare E, Kaighn ME, Weston A, Gerwin BI, Harris CC.

Environ Health Perspect. 1991 Jun;93:133-44. Review.

7.

Role of proto-oncogene activation in carcinogenesis.

Anderson MW, Reynolds SH, You M, Maronpot RM.

Environ Health Perspect. 1992 Nov;98:13-24. Review.

8.

p53 mutation heterogeneity in cancer.

Soussi T, Lozano G.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. Review.

PMID:
15865939
9.

P53 tumor suppressor gene therapy for cancer.

Nielsen LL, Maneval DC.

Cancer Gene Ther. 1998 Jan-Feb;5(1):52-63. Review.

PMID:
9476967
10.

[p53 as a molecular target for cancer therapy].

Ishioka C, Osada M, Gamo M, Kanamaru R.

Gan To Kagaku Ryoho. 1997 Dec;24(15):2207-12. Review. Japanese.

PMID:
9422063
11.

Therapeutic targeting of the p53 tumor suppressor gene.

Beaudry GA, Bertelsen AH, Sherman MI.

Curr Opin Biotechnol. 1996 Dec;7(6):592-600. Review.

PMID:
8939636
12.

In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.

Kenzelmann Broz D, Attardi LD.

Carcinogenesis. 2010 Aug;31(8):1311-8. doi: 10.1093/carcin/bgp331. Epub 2010 Jan 22. Review.

13.

Adenovirus-mediated p53 gene therapy for human cancer.

Fujiwara T, Kataoka M, Tanaka N.

Mol Urol. 2000 Summer;4(2):51-4. Review.

PMID:
12006242
14.

Transcription regulation by mutant p53.

Weisz L, Oren M, Rotter V.

Oncogene. 2007 Apr 2;26(15):2202-11. Review.

PMID:
17401429
15.

Oncogenes and tumor suppressor genes as paradigms in oncogenesis.

Spandidos DA.

J BUON. 2007 Sep;12 Suppl 1:S9-12. Review.

PMID:
17935284
16.

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D.

Br J Cancer. 1994 Mar;69(3):409-16. Review.

17.

Biological and clinical importance of the p53 tumor suppressor gene.

Velculescu VE, El-Deiry WS.

Clin Chem. 1996 Jun;42(6 Pt 1):858-68. Review.

18.

Recent advances in p53 research and cancer treatment.

Suzuki K, Matsubara H.

J Biomed Biotechnol. 2011;2011:978312. doi: 10.1155/2011/978312. Epub 2011 Jun 16. Review.

19.

p53 as a potential target in cancer therapy.

Ozturk M, Ponchel F, Puisieux A.

Bone Marrow Transplant. 1992;9 Suppl 1:164-70. Review. No abstract available.

PMID:
1504661
20.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413

Supplemental Content

Support Center